Search Result For: ckm syndrome
Date: 2025/04/04 - 12:31
New blood test may help diagnose, show how far Alzheimer’s has progressed
Researchers have developed a blood test based on a protein biomarker for tau tangles that can help diagnose Alzheimer’s disease and also provide insight on how far the disease has progressed.
Date: 2025/04/02 - 23:32
Compounded GLP-1s Helped Them Lose Weight, But New FDA Rule Could Block Access
The FDA's new rule restricting the sale of compounded semaglutide could make it more difficult for some people to obtain affordable weight loss medications. Here, two people who've relied on compounded GLP-1 drugs share their stories.
Date: 2025/04/02 - 23:00
Compounded GLP-1s Helped Them Lose Weight, But New FDA Rule Could Block Access
The FDA's new rule restricting the sale of compounded semaglutide could make it more difficult for some people to obtain affordable weight loss medications. Here, two people who've relied on compounded GLP-1 drugs share their stories.
Date: 2025/03/30 - 18:32
He Was Diagnosed With Colon Cancer at 38. Early Warning Signs He Missed
While CRC is on the rise in people under 50, receiving colonoscopies beginning at age 45 can help decrease your risk. Additionally, making lifestyle changes can also help reduce your risk for CRC.
Date: 2025/03/27 - 18:00
Expert Q&A: What are the long-term effects of measles in kids and adults?
Although measles is seen as a contagious viral disease that passes quickly, it can also cause damage that leaves long-term health effects. A measles infection can lead to a phenomenon called 'immune amnesia,' which affects the body's ability to fight off other infections.
Date: 2025/03/20 - 23:32
Two Studies Link Cannabis Use to Substantially Higher Risk of Heart Attack
A retrospective study found that cannabis users were six times as likely to have a heart attack compared to non-users, while a large meta-analysis of 12 previous studies showed that cannabis users had a 50% higher risk of a heart attack.
Date: 2025/03/20 - 00:00
Compounding Pharmacies to Stop Making Ozempic, Zepound Knockoffs: What to Know
The FDA ordered compounding pharmacies to stop making copycat versions of weight loss drugs like Ozempic and Zepbound now that the GLP-1 drug shortage has ended. People who rely on compounded GLP-1s say they may not be able to afford brand-name versions, which are often not covered by insurance.
Date: 2025/03/17 - 15:01
Mounjaro can boost weight loss in people without diabetes
People without diabetes can lose up to 13% of their starting weight in 6 months using tirzepatide (Mounjaro) as an off-label treatment, according to a new study funded by pharmaceutical company Eli Lilly.